CCM
Consonance Capital Management’s Karyopharm Therapeutics KPTI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-6,491,812
| Closed | -$123M | – | 33 |
|
|
2020
Q2 | $123M | Sell |
6,491,812
-688,888
| -10% | -$13M | 7.37% | 2 |
|
|
2020
Q1 | $138M | Buy |
7,180,700
+1,053,266
| +17% | +$20.2M | 10.27% | 1 |
|
|
2019
Q4 | $117M | Buy |
6,127,434
+290,000
| +5% | +$5.56M | 7.17% | 3 |
|
|
2019
Q3 | $56.2M | Buy |
5,837,434
+34,207
| +0.6% | +$329K | 5.56% | 7 |
|
|
2019
Q2 | $34.8M | Buy |
5,803,227
+644,343
| +12% | +$3.86M | 2.46% | 15 |
|
|
2019
Q1 | $30.1M | Buy |
5,158,884
+348,806
| +7% | +$2.04M | 1.9% | 17 |
|
|
2018
Q4 | $45.1M | Sell |
4,810,078
-17,000
| -0.4% | -$159K | 3.31% | 13 |
|
|
2018
Q3 | $82.2M | Buy |
4,827,078
+60,000
| +1% | +$1.02M | 4.43% | 8 |
|
|
2018
Q2 | $81M | Buy |
+4,767,078
| New | +$81M | 5.22% | 6 |
|